FDA approves new drug for schizophrenia, major depression
(HealthDay)—A new drug to treat schizophrenia and depression has been approved by the U.S. Food and Drug Administration.
Jul 13, 2015
0
128
(HealthDay)—A new drug to treat schizophrenia and depression has been approved by the U.S. Food and Drug Administration.
Jul 13, 2015
0
128
Some highly effective medications also happen to be highly mysterious. Such is the case with the antidepressant drugs known as selective serotonin reuptake inhibitors, or SSRIs: They are the most common treatment for major ...
Aug 14, 2020
0
281
Researchers at Washington University School of Medicine in St. Louis are studying the use of nitrous oxide—laughing gas—as a treatment for patients who are hospitalized due to suicidal thoughts. They are investigating ...
Nov 10, 2017
0
48
The difficulties that people have in discontinuing antidepressant medications has been in the news recently. An analysis published in the current issue of Psychotherapy and Psychosomatics on the effects of discontinuing commonly ...
Sep 13, 2018
0
58
Winter is upon us. And with it comes the annual worsening of depressive symptoms. Sadly, in the United States, suicide continues to claim more lives than firearms, and suicide rates are increasing in nearly all states. The ...
Nov 14, 2018
0
7
When Laura Wylie became pregnant for the second time, she confronted a vexing dilemma: Stay on the antidepressants that could have adverse effects on her developing baby or risk descending into a deep, black hole that left ...
May 5, 2015
0
35
Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment. The results of ...
Oct 29, 2018
0
21
In 2004, concerns about antidepressant drugs increasing suicidal thoughts and behaviors in young patients prompted the FDA to issue a rare "black box warning." Now, a new analysis of clinical trial data finds that treatment ...
Feb 6, 2012
0
0
(HealthDay) -- The Israeli drug maker Teva Pharmaceuticals has gained the first U.S. approval to market generic Lexapro (escitalopram) to treat depression and general anxiety disorder, the U.S. Food and Drug Administration ...
Mar 14, 2012
0
0
Researchers from the Icahn School of Medicine at Mount Sinai have identified a drug that works against depression by a completely different mechanism than existing treatments.
Mar 3, 2021
0
37